{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:49:12Z","timestamp":1789771752174,"version":"4.0.1"},"reference-count":29,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"22","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2020,8,1]]},"abstract":"<jats:sec><jats:title>PURPOSE<\/jats:title><jats:p> Three new therapies have been approved recently for the adjuvant treatment of stage III melanoma, substantially reducing the risk of tumor recurrences. This study evaluates 3 independent data sets to clarify the survival probabilities of patients with stage III melanoma. <\/jats:p><\/jats:sec><jats:sec><jats:title>PATIENTS AND METHODS<\/jats:title><jats:p> The Central Malignant Melanoma Registry (CMMR) evaluated 1,553 patients with a primary diagnosis of stage III melanoma from 2000 to 2012. Studies from the European Organisation for Research and Treatment of Cancer (EORTC), of 573 patients in the observation arm of the 18991 study and 445 patients in the placebo arm of the 18071 study, were evaluated as reference cohorts. The survival outcomes were compared with the published American Joint Committee on Cancer version 8 (AJCCv8) stage III survival data. <\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p> For the CMMR stage III cohort versus the AJCCv8 cohort, the melanoma-specific survival (MSS) rates at 5 years were 67% versus 77%, and at 10 years were 56% versus 69%, respectively. For stage IIIA, the MSS rates at 5 years were 80% versus 93%, and at 10 years were 71% versus 88%; for stage IIIB, the MSS rates at 5 years were 75% versus 83%, and at 10 years were 61% versus 77%. The MSS rates of the EORTC studies either overlapped with or were lower than, the CMMR data. <\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p> The MSS rates in the CMMR and EORTC cohorts over the entire stage III are less favorable than those published in AJCCv8. This is particularly true for substages IIIA and IIIB. <\/jats:p><\/jats:sec>","DOI":"10.1200\/jco.19.03034","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T19:59:42Z","timestamp":1591991982000},"page":"2543-2551","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":66,"title":["Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts"],"prefix":"10.1200","volume":"38","author":[{"given":"Claus","family":"Garbe","sequence":"first","affiliation":[{"name":"Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Keim","sequence":"additional","affiliation":[{"name":"Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Suciu","sequence":"additional","affiliation":[{"name":"European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Amaral","sequence":"additional","affiliation":[{"name":"Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Eigentler","sequence":"additional","affiliation":[{"name":"Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Gesierich","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Wuerzburg, Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Hauschild","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Heinzerling","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Erlangen, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Kiecker","sequence":"additional","affiliation":[{"name":"Skin Cancer Center, Department of Dermatology, Charit\u00e9 Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Schadendorf","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Essen, Essen, & German Cancer Consortium, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Stadler","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Johannes Wesling Hospital Minden, Ruhr-University of Bochum, Minden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cord","family":"Sunderk\u00f6tter","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital Halle, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"T\u00fcting","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Magdeburg, Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Utikal","sequence":"additional","affiliation":[{"name":"Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Wollina","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology, Municipal Hospital of Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos C.","family":"Zouboulis","sequence":"additional","affiliation":[{"name":"Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane, Dessau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Keilholz","sequence":"additional","affiliation":[{"name":"Charit\u00e9, Campus Benjamin Franklin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Testori","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Martus","sequence":"additional","affiliation":[{"name":"Institute of Clinical Epidemiology and Applied Biostatistics, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Leiter","sequence":"additional","affiliation":[{"name":"Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M. M.","family":"Eggermont","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the German Central Malignant Melanoma Registry and the European Organisation for Research and Treatment of Cancer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15322"},{"key":"B2","first-page":"120","volume":"810","author":"Leiter U","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0048-5"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_200241"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30596-5"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-22539-5_5"},{"key":"B7","doi-asserted-by":"crossref","unstructured":"Crompton JG, Gilbert E, Brady MS: Clinical implications of the eighth edition of the American Joint Committee on Cancer melanoma staging. J Surg Oncol 119:168-174, 2019","DOI":"10.1002\/jso.25343"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.16.3635"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4799"},{"key":"B10","doi-asserted-by":"crossref","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, et al: Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67:472-492, 2017","DOI":"10.3322\/caac.21409"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.11.023"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15285"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2018.06.003"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000915)89:6<1269::AID-CNCR11>3.0.CO;2-C"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61033-8"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.41.3799"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70122-1"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611299"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.07.001"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21876"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.09.013"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.06.028"},{"key":"B24","doi-asserted-by":"crossref","unstructured":"Kanaki T, Stang A, Gutzmer R, et al: Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma. Eur J Cancer 119:18-29, 2019","DOI":"10.1016\/j.ejca.2019.06.011"},{"key":"B25","doi-asserted-by":"crossref","unstructured":"Isaksson K, Katsarelias D, Mikiver R, et al: A population-based comparison of the AJCC 7th and AJCC 8th editions for patients diagnosed with stage III cutaneous malignant melanoma in Sweden. Ann Surg Oncol 26:2839-2845, 2019","DOI":"10.1245\/s10434-019-07448-y"},{"key":"B26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1056\/NEJMc1715454","volume":"378","author":"Weber J","year":"2018","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709030"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802357"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708539"},{"key":"B30","doi-asserted-by":"crossref","unstructured":"Gershenwald JE, Scolyer RA: Melanoma staging: American Joint Committee on Cancer (AJCC) 8th edition and beyond. Ann Surg Oncol 25:2105-2110, 2018 [Erratum: Ann Surg Oncol 2018]","DOI":"10.1245\/s10434-018-6513-7"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.19.03034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T08:04:08Z","timestamp":1653811448000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.19.03034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":29,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2020,8,1]]}},"alternative-id":["10.1200\/JCO.19.03034"],"URL":"https:\/\/doi.org\/10.1200\/jco.19.03034","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]},"assertion":[{"value":"2020-06-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}